Trial Details
COMPLETEDBasic Information
| Clinical ID | c2782 |
|---|---|
| Identifier | NCT02968108 |
| Trial Title | A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-01-18 |
|---|---|
| Primary Completion Date | 2018-09-19 |
| Completion Date | 2022-03-18 |